RXFP4
Relaxin-3 receptor 2
Also known as: GPCR142, GPR100, RL3R2_HUMAN, RLN3R2, RXFPR4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDU9
- Gene
- RXFP4
- Ensembl
- ENSG00000173080
- Chromosome
- 1
- Canonical length
- 374 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
GPR100 is a member of the rhodopsin family of G protein-coupled receptors (GPRs) (Fredriksson et al., 2003 [PubMed 14623098]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
374 residues, UniProt reviewed canonical sequence.
>Q8TDU9|RXFP4
1 MPTLNTSASP PTFFWANASG GSVLSADDAP MPVKFLALRL MVALAYGLVG AIGLLGNLAV
61 LWVLSNCARR APGPPSDTFV FNLALADLGL ALTLPFWAAE SALDFHWPFG GALCKMVLTA
121 TVLNVYASIF LITALSVARY WVVAMAAGPG THLSLFWARI ATLAVWAAAA LVTVPTAVFG
181 VEGEVCGVRL CLLRFPSRYW LGAYQLQRVV LAFMVPLGVI TTSYLLLLAF LQRRQRRRQD
241 SRVVARSVRI LVASFFLCWF PNHVVTLWGV LVKFDLVPWN STFYTIQTYV FPVTTCLAHS
301 NSCLNPVLYC LLRREPRQAL AGTFRDLRLR LWPQGGGWVQ QVALKQVGRR WVASNPRESR
361 PSTLLTNLDR GTPGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RXFP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 1.8 nTPM
Expression across tissuesHPA
Tissue
- colon: 1.8 nTPM
- rectum: 1.7 nTPM
- duodenum: 1.3 nTPM
- small intestine: 0.8 nTPM
- bone marrow: 0.6 nTPM
- appendix: 0.2 nTPM
Single-cell type
- neuroendocrine cells: 51 nCPM
- enteric stem cells: 5 nCPM
- colonocytes: 3.8 nCPM
- enteric transient amplifying cells: 3.8 nCPM
- goblet cells: 2.8 nCPM
- gastric progenitor cells: 1.3 nCPM
Immune cell
- eosinophil: 0.2 nTPM
- intermediate monocyte: 0.2 nTPM
- non-classical monocyte: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
Brain region
- cerebellum: 4.8 nTPM
- basal ganglia: 1.5 nTPM
- cerebral cortex: 1.5 nTPM
- pons: 1.3 nTPM
- white matter: 1.1 nTPM
- medulla oblongata: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RXFP4 as an antibody target. Whether an autoantibody or antibody against RXFP4 could matter depends on whether native RXFP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RXFP4 is annotated at the cell surface, where native RXFP4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RXFP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...